| Outcome Measures: |
Primary: Change in HbA1c (Glycated haemoglobin), %-points, From baseline (week 0) to End of Study visit (V3) (week 34-44) | Secondary: Relative change in body weight, From baseline (week 0) to End of Study visit (V3) (week 34-44)|Absolute change in body weight, Kilogram (Kg), From baseline (week 0) to End of Study visit (V3) (week 34-44)|HbA1c below 7%, Yes or No, End of Study visit (V3) (week 34-44)|HbA1c reduction greater than or equal to 1%-points and body weight reduction of greater than or equal to 5%, Yes or No, From baseline (week 0) to End of Study visit (V3) (week 34-44)|HbA1c reduction greater than or equal to 1%-points and body weight reduction of greater than or equal to 3%, Yes or No, From baseline (week 0) to End of Study visit (V3) (week 34-44)|DTSQc (Diabetes Treatment Satisfaction Questionnaire, change), relative treatment satisfaction, Total score, End of Study visit (V3) (week 34-44)|DTSQs (Diabetes Treatment Satisfaction Questionnaire, status), change in absolute treatment satisfaction From baseline (week 0) to, Total score, End of Study visit (V3) (week 34-44)
|
